Literature DB >> 25708447

Uptake and metabolism of fructose by rat neocortical cells in vivo and by isolated nerve terminals in vitro.

Bjørnar Hassel1, Ahmed Elsais, Anne-Sofie Frøland, Erik Taubøll, Leif Gjerstad, Yi Quan, Raymond Dingledine, Frode Rise.   

Abstract

Fructose reacts spontaneously with proteins in the brain to form advanced glycation end products (AGE) that may elicit neuroinflammation and cause brain pathology, including Alzheimer's disease. We investigated whether fructose is eliminated by oxidative metabolism in neocortex. Injection of [(14) C]fructose or its AGE-prone metabolite [(14) C]glyceraldehyde into rat neocortex in vivo led to formation of (14) C-labeled alanine, glutamate, aspartate, GABA, and glutamine. In isolated neocortical nerve terminals, [(14) C]fructose-labeled glutamate, GABA, and aspartate, indicating uptake of fructose into nerve terminals and oxidative fructose metabolism in these structures. This was supported by high expression of hexokinase 1, which channels fructose into glycolysis, and whose activity was similar with fructose or glucose as substrates. By contrast, the fructose-specific ketohexokinase was weakly expressed. The fructose transporter Glut5 was expressed at only 4% of the level of neuronal glucose transporter Glut3, suggesting transport across plasma membranes of brain cells as the limiting factor in removal of extracellular fructose. The genes encoding aldose reductase and sorbitol dehydrogenase, enzymes of the polyol pathway that forms glucose from fructose, were expressed in rat neocortex. These results point to fructose being transported into neocortical cells, including nerve terminals, and that it is metabolized and thereby detoxified primarily through hexokinase activity. We asked how the brain handles fructose, which may react spontaneously with proteins to form 'advanced glycation end products' and trigger inflammation. Neocortical cells took up and metabolized extracellular fructose oxidatively in vivo, and isolated nerve terminals did so in vitro. The low expression of fructose transporter Glut5 limited uptake of extracellular fructose. Hexokinase was a main pathway for fructose metabolism, but ketohexokinase (which leads to glyceraldehyde formation) was expressed too. Neocortical cells also took up and metabolized glyceraldehyde oxidatively.
© 2015 International Society for Neurochemistry.

Entities:  

Keywords:  Alzheimer's disease; Glut5; brain metabolism; fructose; glyceraldehyde; ketohexokinase

Mesh:

Substances:

Year:  2015        PMID: 25708447      PMCID: PMC4427911          DOI: 10.1111/jnc.13079

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  48 in total

1.  Glyceraldehyde-derived advanced glycation end products in Alzheimer's disease.

Authors:  Hiroshi Choei; Nobuyuki Sasaki; Masayoshi Takeuchi; Taku Yoshida; Wataru Ukai; Sho-Ichi Yamagishi; Seiji Kikuchi; Toshikazu Saito
Journal:  Acta Neuropathol       Date:  2004-06-17       Impact factor: 17.088

2.  Multimolecular forms of pyruvate kinase. II. Purification of M 2 -type pyruvate kinase from Yoshida ascites hepatoma 130 cells and comparative studies on the enzymological and immunological properties of the three types of pyruvate kinases, L, M 1 , and M 2 .

Authors:  K Imamura; K Taniuchi; T Tanaka
Journal:  J Biochem       Date:  1972-10       Impact factor: 3.387

3.  Permeability of the blood-brain barrier to fructose and the anaerobic use of fructose in the brains of young mice.

Authors:  J H Thurston; C A Levy; S K Warren; E M Jones
Journal:  J Neurochem       Date:  1972-07       Impact factor: 5.372

4.  Brain uptake of radiolabeled amino acids, amines, and hexoses after arterial injection.

Authors:  W H Oldendorf
Journal:  Am J Physiol       Date:  1971-12

5.  Sequence, tissue distribution, and functional characterization of the rat fructose transporter GLUT5.

Authors:  E B Rand; A M Depaoli; N O Davidson; G I Bell; C F Burant
Journal:  Am J Physiol       Date:  1993-06

6.  Polyol accumulations in nervous tissue of rats with experimental diabetes and galactosaemia.

Authors:  M A Stewart; W R Sherman; M M Kurien; G I Moonsammy; M Wisgerhof
Journal:  J Neurochem       Date:  1967-11       Impact factor: 5.372

7.  Cerebral metabolism of lactate in vivo: evidence for neuronal pyruvate carboxylation.

Authors:  B Hassel; A Bråthe
Journal:  J Cereb Blood Flow Metab       Date:  2000-02       Impact factor: 6.200

Review 8.  Fructose-mediated non-enzymatic glycation: sweet coupling or bad modification.

Authors:  Casper G Schalkwijk; Coen D A Stehouwer; Victor W M van Hinsbergh
Journal:  Diabetes Metab Res Rev       Date:  2004 Sep-Oct       Impact factor: 4.876

9.  Reduction of trioses by NADPH-dependent aldo-keto reductases. Aldose reductase, methylglyoxal, and diabetic complications.

Authors:  D L Vander Jagt; B Robinson; K K Taylor; L A Hunsaker
Journal:  J Biol Chem       Date:  1992-03-05       Impact factor: 5.157

10.  Cloning and functional characterization of the human GLUT7 isoform SLC2A7 from the small intestine.

Authors:  Qiang Li; Andrei Manolescu; Mabel Ritzel; Sylvia Yao; Melissa Slugoski; James D Young; Xing-Zhen Chen; Chris I Cheeseman
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2004-03-19       Impact factor: 4.052

View more
  16 in total

1.  Metabolism of Mannose in Cultured Primary Rat Neurons.

Authors:  Wiebke Rastedt; Eva-Maria Blumrich; Ralf Dringen
Journal:  Neurochem Res       Date:  2017-03-27       Impact factor: 3.996

Review 2.  Formation of Fructose-Mediated Advanced Glycation End Products and Their Roles in Metabolic and Inflammatory Diseases.

Authors:  Alejandro Gugliucci
Journal:  Adv Nutr       Date:  2017-01-17       Impact factor: 8.701

3.  Specific regions of the brain are capable of fructose metabolism.

Authors:  Sarah A Oppelt; Wanming Zhang; Dean R Tolan
Journal:  Brain Res       Date:  2016-12-27       Impact factor: 3.252

4.  Short-Term Fructose Feeding Induces Inflammation and Oxidative Stress in the Hippocampus of Young and Adult Rats.

Authors:  Luisa Cigliano; Maria Stefania Spagnuolo; Raffaella Crescenzo; Rosa Cancelliere; Lucia Iannotta; Arianna Mazzoli; Giovanna Liverini; Susanna Iossa
Journal:  Mol Neurobiol       Date:  2017-04-28       Impact factor: 5.590

5.  Pyridoxamine and Aminoguanidine Attenuate the Abnormal Aggregation of β-Tubulin and Suppression of Neurite Outgrowth by Glyceraldehyde-Derived Toxic Advanced Glycation End-Products.

Authors:  Hayahide Ooi; Ryuto Nasu; Ayako Furukawa; Masayoshi Takeuchi; Yoshiki Koriyama
Journal:  Front Pharmacol       Date:  2022-06-03       Impact factor: 5.988

Review 6.  Glucose transporters in brain in health and disease.

Authors:  Hermann Koepsell
Journal:  Pflugers Arch       Date:  2020-08-13       Impact factor: 3.657

7.  Glyceraldehyde caused Alzheimer's disease-like alterations in diagnostic marker levels in SH-SY5Y human neuroblastoma cells.

Authors:  Yoshiki Koriyama; Ayako Furukawa; Michiru Muramatsu; Jun-ichi Takino; Masayoshi Takeuchi
Journal:  Sci Rep       Date:  2015-08-25       Impact factor: 4.379

8.  Evaluation of the In Vivo and In Vitro Effects of Fructose on Respiratory Chain Complexes in Tissues of Young Rats.

Authors:  Ernesto António Macongonde; Thais Ceresér Vilela; Giselli Scaini; Cinara Ludvig Gonçalves; Bruna Klippel Ferreira; Naithan Ludian Fernandes Costa; Marcos Roberto de Oliveira; Silvio Avila Junior; Emilio Luiz Streck; Gustavo Costa Ferreira; Patrícia Fernanda Schuck
Journal:  Dis Markers       Date:  2015-12-06       Impact factor: 3.434

9.  Consumption of Alcopops During Brain Maturation Period: Higher Impact of Fructose Than Ethanol on Brain Metabolism.

Authors:  Dounia El Hamrani; Henri Gin; Jean-Louis Gallis; Anne-Karine Bouzier-Sore; Marie-Christine Beauvieux
Journal:  Front Nutr       Date:  2018-05-08

10.  The Glutamine Transporter Slc38a1 Regulates GABAergic Neurotransmission and Synaptic Plasticity.

Authors:  Tayyaba Qureshi; Christina Sørensen; Paul Berghuis; Vidar Jensen; Marton B Dobszay; Tamás Farkas; Knut Tomas Dalen; Caiying Guo; Bjørnar Hassel; Tor Paaske Utheim; Øivind Hvalby; Torkel Hafting; Tibor Harkany; Marianne Fyhn; Farrukh Abbas Chaudhry
Journal:  Cereb Cortex       Date:  2019-12-17       Impact factor: 5.357

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.